Cancer of unknown origin in gynaecologic oncology

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F23%3AE0110298" target="_blank" >RIV/00843989:_____/23:E0110298 - isvavai.cz</a>

Výsledek na webu

<a href="https://oss.ejgo.net/files/article/20230615-39/pdf/EJGO2022111301.pdf" target="_blank" >https://oss.ejgo.net/files/article/20230615-39/pdf/EJGO2022111301.pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.22514/ejgo.2023.045" target="_blank" >10.22514/ejgo.2023.045</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Cancer of unknown origin in gynaecologic oncology

Popis výsledku v původním jazyce

Tumour of unknown primary (primum ignotum) is a metastatic disease that generally shows a poor response to treatment and prognosis. Although it exhibits a trend of decreasing incidence, the diagnostic processes are complicated. The available literature shows that 5–30% of metastases involve the ovary, but it remains unclear how often ovarian infiltration is found in tumours of unknown primary. The most common metastatic disease that affects the ovaries are malignant tumours of the gastrointestinal tract, breast, pancreas, and haematological malignancies. Usually, the first step to distinguish between a primary and a secondary tumour of the ovary is an ultrasound examination, where the ovarian metastases have some characteristic features. Here we report our experience with primum ignotum in a patient with simultaneous ovarian and bone marrow involvement.

Název v anglickém jazyce

Cancer of unknown origin in gynaecologic oncology

Popis výsledku anglicky

Tumour of unknown primary (primum ignotum) is a metastatic disease that generally shows a poor response to treatment and prognosis. Although it exhibits a trend of decreasing incidence, the diagnostic processes are complicated. The available literature shows that 5–30% of metastases involve the ovary, but it remains unclear how often ovarian infiltration is found in tumours of unknown primary. The most common metastatic disease that affects the ovaries are malignant tumours of the gastrointestinal tract, breast, pancreas, and haematological malignancies. Usually, the first step to distinguish between a primary and a secondary tumour of the ovary is an ultrasound examination, where the ovarian metastases have some characteristic features. Here we report our experience with primum ignotum in a patient with simultaneous ovarian and bone marrow involvement.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30214 - Obstetrics and gynaecology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European journal of gynaecological oncology

ISSN

0392-2936

e-ISSN

2709-0086

Svazek periodika

44

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CA - Kanada

Počet stran výsledku

4

Strana od-do

102-105

Kód UT WoS článku

001016563600014

EID výsledku v databázi Scopus

—